Literature DB >> 13007362

Purified precipitated virus obtained by a new simple method.

G TAKATSY.   

Abstract

Keywords:  INFLUENZA VIRUS; MUMPS; NEWCASTLE DISEASE; VIRUSES

Mesh：

Year:  1952        PMID： 13007362

Source DB:  PubMed          Journal:  Acta Med Acad Sci Hung        ISSN： 0001-5989


× No keyword cloud information.
  6 in total

1.  Examination of a purified A' influenza virus preparation by potentiometry.

Authors:  A KOCH
Journal:  Arch Gesamte Virusforsch       Date:  1962

2.  On the antigenic variation of the influenza A virus.

Authors:  G TAKATSY; J FURESZ
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development.

Authors:  Zoltan Vajo; John Wood; Lajos Kosa; Istvan Szilvasy; Gyorgy Paragh; Zsuzsanna Pauliny; Kálmán Bartha; Ildiko Visontay; Agnes Kis; Istvan Jankovics
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to clade 1 strains.

Authors:  György Fazekas; Rita Martosne-Mendi; Istvan Jankovics; Istvan Szilvasy; Zoltan Vajo
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

5.  Inactivated whole virus influenza A (H5N1) vaccine.

Authors:  Zoltan Vajo; Lajos Kosa; Ildiko Visontay; Mate Jankovics; Istvan Jankovics
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

6.  Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

Authors:  Zoltan Vajo; Lajos Kosa; Istvan Szilvasy; Zsuzsanna Pauliny; Kálmán Bartha; Ildiko Visontay; Mate Jankovics; Agnes Kis; Istvan Jankovics
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.